Abstract Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease in
which many processes are detected including (neuro) inflammation. Many drugs have been …

Amyotrophic lateral sclerosis (ALS) is a rapidly debilitating fatal neurodegenerative disorder,
causing muscle atrophy and weakness, which leads to paralysis and eventual death. ALS …

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease
that leads to the massive loss of motor neurons in cerebrum, brain stem and spinal cord. It …

Pharmaceutics: Basic Principles and Application to Pharmacy Practice, Second Edition is a
valuable textbook covering the role and application of pharmaceutics within pharmacy …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects the first
and second motoneurons (MNs), associated with muscle weakness, paralysis and finally …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease for which few
effective therapeutic strategies are available. Increasing evidence indicates that …

Numerous potential amyotrophic lateral sclerosis (ALS)‐relevant pathways have been
hypothesized and studied preclinically, with subsequent translation to clinical trial. However …

Pharmacogenomics (PGx) stands at the heart of Precision Medicine. It combines the science
of pharmacology and genomics to personalize patients' medications based on their genetic …

Stem cells have been the subject of research for years due to their enormous therapeutic
potential. Most neurological diseases such as multiple sclerosis (MS), amyotrophic lateral …

Résumé La sclérose latérale amyotrophique (SLA) est caractérisée par la mort progressive
des neurones de la voie motrice principale. Il en résulte une perte de la motricité volontaire …